If you made any changes in Pure these will be visible here soon.

Fingerprint Dive into the research topics where Caterina Gori is active. These topic labels come from the works of this person. Together they form a unique fingerprint.

  • 61 Similar Profiles
HIV-1 Medicine & Life Sciences
Mutation Medicine & Life Sciences
Drug Resistance Medicine & Life Sciences
HIV Medicine & Life Sciences
Viremia Medicine & Life Sciences
Pharmaceutical Preparations Medicine & Life Sciences
Highly Active Antiretroviral Therapy Medicine & Life Sciences
Italy Medicine & Life Sciences

Network Recent external collaboration on country level. Dive into details by clicking on the dots.

Research Output 2002 2019

  • 985 Citations
  • 20 h-Index
  • 55 Article

Characterisation of HIV-1 molecular transmission clusters among newly diagnosed individuals infected with non-B subtypes in Italy

Fabeni, L., Alteri, C., Berno, G., Scutari, R., Orchi, N., De Carli, G., Bertoli, A., Carioti, L., Gori, C., Forbici, F., Salpini, R., Vergori, A., Gagliardini, R., Cicalini, S., Mondi, A., Pinnetti, C., Mazzuti, L., Turriziani, O., Colafigli, M., Borghi, V. & 10 others, Montella, F., Pennica, A., Lichtner, M., Girardi, E., Andreoni, M., Mussini, C., Antinori, A., Ceccherini-Silberstein, F., Perno, C. F. & Santoro, M. M., Jan 1 2019, In : Sexually Transmitted Infections. p. 1-7 7 p.

Research output: Contribution to journalArticle

CD4 Lymphocyte Count
Logistic Models
Viral Load

HIV-1 drug resistance testing is essential for heavily-treated patients switching from first- to second-line regimens in resource-limited settings: Evidence from routine clinical practice in Cameroon

Takou, D., Fokam, J., Teto, G., Santoro, M. M., Ceccherini-Silberstein, F., Nanfack, A. J., Sosso, S. M., Dambaya, B., Salpini, R., Billong, S. C., Gori, C., Fokunang, C. N., Cappelli, G., Colizzi, V., Perno, C. F. & Ndjolo, A., Mar 12 2019, In : BMC Infectious Diseases. 19, 1, p. 1-9 9 p., 246.

Research output: Contribution to journalArticle

Open Access
Drug Resistance

Integrase strand transfer inhibitor-based regimen is related with a limited HIV-1 V3 loop evolution in clinical practice

Alteri, C., Scutari, R., Bertoli, A., Armenia, D., Gori, C., Fabbri, G., Mastroianni, C. M., Cerva, C., Cristaudo, A., Vicenti, I., Bruzzone, B., Zazzi, M., Andreoni, M., Antinori, A., Svicher, V., Ceccherini-Silberstein, F., Perno, C. F. & Santoro, M. M., Jan 1 2019, In : Virus Genes. p. 290-297 8 p.

Research output: Contribution to journalArticle

Viral Load
Odds Ratio
Confidence Intervals

Very high pre-therapy viral load is a predictor of virological rebound in HIV-1-infected patients starting a modern first-line regimen

ICONA Foundation Study group, Jan 1 2019, In : Antiviral Therapy. 24, 5, p. 321-331 11 p.

Research output: Contribution to journalArticle

A straightforward multiparametric quality control protocol for proton magnetic resonance spectroscopy: Validation and comparison of various 1.5 T and 3 T clinical scanner systems

Sghedoni, R., Coniglio, A., Mazzoni, L. N., Busoni, S., Belli, G., Tarducci, R., Nocetti, L., Fedeli, L., Esposito, M., Ciccarone, A., Altabella, L., Bellini, A., Binotto, L., Caivano, R., Carnì, M., Ricci, A., Cimolai, S., D'Urso, D., Gasperi, C., Levrero, F. & 12 others, Mangili, P., Morzenti, S., Nitrosi, A., Oberhofer, N., Parruccini, N., Toncelli, A., Valastro, L. M., Gori, C., Gobbi, G., Giannelli, M., Quantification, I. A. O. P. I. M. AIFM. W. G. O. & MR, I. I., 2018, In : Physica Medica. 54, p. 49-55 7 p.

Research output: Contribution to journalArticle